Background

The International Trade Commission has recently announced the following actions in intellectual property rights infringement investigations. For more information on pursuing or mitigating IPR-related import restrictions, please contact Lee Sandler at (305) 894-1000.

Audio players – termination of patent infringement investigation 337-TA-1191 of audio players and controllers, components thereof, and products containing the same with respect to one respondent based on complainant Sonos Inc.’s withdrawal of allegations against that respondent

Botulinum toxin – in investigation 337-TA-1145 of botulinum toxin products, processes for manufacturing or relating to same, and certain products containing same, final initial determination of violation by virtue of misappropriation of trade secrets and Oct. 9 deadline for comments on (1) the form of remedy, if any, that should be ordered, (2) the effects of any such remedy on the public interest, and (3) the amount of the bond under which infringing goods could continue to enter the U.S. during the 60-day presidential review period

Digital video devices – new IPR infringement complaint filed on digital video-capable devices and components thereof (complainants Koninklijke Philips N.V. and Philips North America LLC; proposed respondents located in China, Hong Kong, Korea, Mexico, Vietnam, Taiwan, and the U.S.)

Mobile devices – termination of patent infringement investigation 337-TA-1193 of capacitive touch-controlled mobile devices, computers, and components thereof with respect to several patent claims withdrawn by complainant Neodron Ltd.

Copyright © 2024 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 

Close

Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.